Dietary mucilage promotes regression of atheromatous lesions in hypercholesterolemic rabbits

Phytotherapy Research

Volumn 23, Issue 5, 2009, Pages 725-730

  Boban, Puthenpura T ^a   Nambisan, Bala ^b   Sudhakaran, Perumana R ^a  

^a UNIVERSITY OF KERALA   (India)

^b CENTRAL TUBER CROPS RESEARCH INSTITUTE   (India)

Author keywords

Atheromatous lesion; Dietary fiber; Fenugreek; Galactomannan; Mucilage; Regression

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SCARLET RED; TRIACYLGLYCEROL; GALACTOMANNAN; MANNAN; PLANT EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; ARTICLE; ATHEROSCLEROTIC PLAQUE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CHOLESTEROL LIVER LEVEL; CONTROLLED STUDY; CONVALESCENCE; DEFENSE MECHANISM; DIET SUPPLEMENTATION; FENUGREEK; HYPERCHOLESTEROLEMIA; ISOLATION PROCEDURE; LIPID LIVER LEVEL; MALE; MUCILAGE; NONHUMAN; PLANT SEED; PROTEIN BLOOD LEVEL; RABBIT; STAINING; TISSUE LEVEL; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; AORTA DISEASE; ATHEROSCLEROSIS; BLOOD; CHEMISTRY; DIET; DRUG EFFECT; LIVER; METABOLISM;

ANIMALIA; ORYCTOLAGUS CUNICULUS; TRIGONELLA FOENUM-GRAECUM;

ANIMALS; AORTA; AORTIC DISEASES; ATHEROSCLEROSIS; C-REACTIVE PROTEIN; CHOLESTEROL, LDL; DIET; HYPERCHOLESTEROLEMIA; LIVER; MALE; MANNANS; PLANT EXTRACTS; RABBITS; TRIGLYCERIDES; TRIGONELLA;

EID: 65649142141     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2728     Document Type: Article

References (28)

1. Anderson JW. 1995. Dietary fibre, complex carbohydrate and coronary artery disease. Can J Cardiol 11: 55G-62G.
2. Basch E, Ulbricht C, Kuo G, Szapary P, Smith M. 2003. Therapeutic applications of fenugreek. Altern Med Rev 8: 20-27.
3. Boban PT, Nambisan B, Sudhakaran PR. 2006. Hypolipidaemic effect of chemically different mucilages in rats: a comparative study. Br J Nutr 96: 1021-1029.
4. Carr JJ, Drekter IJ. 1956. Simplified rapid technic for the extraction and determination of serum cholesterol without saponification. Clin Chem 2: 353-368.
5. Erkkila AT, Lichtenstein AH. 2006. Fiber and cardiovascular disease risk: how strong is the evidence? J Cardiovasc Nurs 21: 3-8.
6. Evans AJ, Hood RL, Oakenfull DG, Sidhu GS. 1992. Relationship between structure and function of dietary fibre: a comparative study of the effects of three galactomannans on cholesterol metabolism in the rat. Br J Nutr 68: 217-229.
7. Fernandez ML. 2001. Soluble fiber and nondigestible carbohydrate effects on plasma lipids and cardiovascular risk. Curr Opin Lipidol 12: 35-40.
8. Folch J, Lees M, Sloane-Stanley GH. 1957. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226: 497-509.
9. Franz G. 1979. Metabolism of reserve polysaccharides in tubers of Orchis morio L. Planta Med 36: 68-73.
10. Frisinghelli A, Mafrici A. 2007. Regression or reduction in progression of atherosclerosis, and avoidance of coronary events, with lovastatin in patients with or at high risk of cardiovascular disease: a review. Clin Drug Investig 27: 591-604.
11. Galis ZS, Sukhova GK, Kranzhofer R, Clark S, Libby P. 1995. Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases. Proc Natl Acad Sci USA 92: 402-406.
12. Galis ZS, Sukhova GK, Lark MW, Libby P. 1994. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 94: 2493-2503.
13. Hara H, Haga S, Aoyama Y, Kiriyama S. 1999. Short-chain fatty acids suppress cholesterol synthesis in rat liver and intestine. J Nutr 129: 942-948.
14. Hou WC, Hsu FL, Lee MH. 2002. Yam (Dioscorea batatas) tuber mucilage exhibited antioxidant activities in vitro. Planta Med 68: 1072-1076.
15. Kumar GS, Shetty AK, Salimath PV. 2005. Modulatory effect of fenugreek seed mucilage and spent turmeric on intestinal and renal disaccharidases in streptozotocin induced diabetic rats. Plant Foods Hum Nutr 60: 87-91.
16. Libby P, Aikawa M. 2001. Evolution and stabilization of vulnerable atherosclerotic plaques. Jpn Circ J 65: 473-479.
17. Libby P, Aikawa M. 2002. Stabilization of atherosclerotic plaques: new mechanisms and clinical targets. Nat Med 8: 1257-1262.
18. Libby P. 2002. Inflammation in atherosclerosis. Nature 420: 868-874.
19. Lucas EA, Lightfoot SA, Hammond LJ et al. 2004. Flaxseed reduces plasma cholesterol and atherosclerotic lesion formation in ovariectomized Golden Syrian hamsters. Atherosclerosis 173: 223-229.
20. Matsumoto S, Kobayashi T, Katoh M et al. 1998. Expression and localization of matrix metalloproteinase-12 in the aorta of cholesterol-fed rabbits: relationship to lesion development. Am J Pathol 153: 109-119.
21. Oka K, Chan L. 2005. Inhibition and regression of atherosclerotic lesions. Acta Biochim Pol 52: 311-319.
22. Ridker PM, Hennekens CH, Buring JE, Rifai N. 2000. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342: 836-843.
23. Shah PK. 2002. Low-density lipoprotein lowering and atherosclerosis progression: does more mean less? Circulation 106: 2039-2040.
24. Truswell AS. 1995. Dietary fiber and blood lipids. Curr Opin Lipidol 6: 14-19.
25. van Handel E, Zilversmit DB. 1957. Micromethod for the direct determination of serum triglycerides. J Lab Clin Med 50: 152-157.
26. Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. 2000. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 20: 1262-1275.
27. Watanabe T, Tokunaga O, Fan JL, Shimokama T. 1989. Atherosclerosis and macrophages. Acta Pathol Jpn 39: 473-486.
28. Yanni AE. 2004. The laboratory rabbit: an animal model of atherosclerosis research. Lab Anim 38: 246-256.